Literature DB >> 14228138

CENTRAL CARDIOVASCULAR ACTIONS OF GAMMA-AMINOBUTYRIC ACID.

K P BHARGAVA, S S BHATTACHARYA, R C SRIMAL.   

Abstract

The vasomotor and cardiac effects of gamma-aminobutyric acid (GABA) administered by different routes were studied in cats and dogs. The cat was resistant to the action of GABA administered intravenously or into a vertebral artery. Intrathecal injection of GABA into the cat depressed the vasomotor reponse to spinal compression. In dogs, intravenous, intrathecal or intraventricular injection, or topical application of GABA to the floor of 4th ventricle consistently produced hypotension and depressed the reflex and direct excitability of the vasomotor neurones, located at the supraspinal and spinal levels. Bradycardia observed after intravenous and intraventricular injections of GABA into dogs was abolished by stellate ganglionectomy but not by vagotomy. It has been attributed to depression of the central sympathetic neurones.

Entities:  

Keywords:  AMINOBUTYRIC ACID; BRADYCARDIA; CATS; DOGS; EXPERIMENTAL LAB STUDY; HEART; HEART RATE; HYPOTENSION; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRATHECAL; INJECTIONS, INTRAVENOUS; PHARMACOLOGY; REFLEX; SPINAL CORD; SYMPATHECTOMY; VAGOTOMY; VASOMOTOR SYSTEM

Mesh:

Substances:

Year:  1964        PMID: 14228138      PMCID: PMC1704100          DOI: 10.1111/j.1476-5381.1964.tb01594.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  9 in total

1.  Mode of action of gamma amino butyric acid on the cardiovascular system.

Authors:  H C STANTON
Journal:  Arch Int Pharmacodyn Ther       Date:  1963-05-01

2.  The effect of gamma-amino-n-butyric acid and some related compounds on the cardiovascular system of anesthetized dogs.

Authors:  H C STANTON; F H WOODHOUSE
Journal:  J Pharmacol Exp Ther       Date:  1960-03       Impact factor: 4.030

3.  The spinal compression vasomotor response as a pharmacological tool.

Authors:  K P BHARGAVA; J K KULSRESHTHA
Journal:  Arch Int Pharmacodyn Ther       Date:  1959-05-01

4.  On the site of action of gamma-aminobutyric acid on blood pressure.

Authors:  H TAKAHASHI; M TIBA; T YAMAZAKI; F NOGUCHI
Journal:  Jpn J Physiol       Date:  1958-12-20

5.  gamma Aminobutyric acid; circulatory and respiratory effects in different species; re-investigation of the anti-strychnine action in mice.

Authors:  K A ELLIOTT; F HOBBIGER
Journal:  J Physiol       Date:  1959-04-23       Impact factor: 5.182

6.  Localisation of the central site of hypotensive action of chlorpromazine.

Authors:  K K TANGRI; K P BHARGAVA
Journal:  Arch Int Pharmacodyn Ther       Date:  1960-09-01

7.  The effect of gamma-aminobutyric acid on blood pressure.

Authors:  H TAKAHASHI; M TIBA; M IINO; T TAKAYASU
Journal:  Jpn J Physiol       Date:  1955-12-15

8.  A NEUROPHARMACOLOGICAL STUDY OF GAMMA-AMINOBUTYRIC ACID (GABA).

Authors:  S S BHATTACHARYA; K KISHOR; P N SAXENA; K P BHARGAVA
Journal:  Arch Int Pharmacodyn Ther       Date:  1964-08-01

9.  The central vasomotor effects of 5-hydroxytryptamie.

Authors:  K P BHARGAVA; K K TANGRI
Journal:  Br J Pharmacol Chemother       Date:  1959-12
  9 in total
  9 in total

1.  Effects of gamma-vinyl GABA (vigabatrin) on blood pressure and body weight of hypertensive and normotensive rats.

Authors:  N Singewald; A Pfitscher; A Philippu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

2.  Superfusion of the hypothalamus with gamma-aminobutyric acid. Effect on release of noradrenaline and blood pressure.

Authors:  A Philippu; H Przuntek; W Roensberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

3.  Evidence for the involvement of a GABA-mediated inhibition in the hypovolaemia-induced vasopressin release.

Authors:  W Knepel; D Nutto; G Hertting
Journal:  Pflugers Arch       Date:  1980-11       Impact factor: 3.657

4.  Evidence for a spinal origin of the effect of baclofen on the myocardial oxygen demand indexes.

Authors:  L Monassier; E Tibiriça; J C Roegel; J Feldman; P Bousquet
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-11       Impact factor: 3.000

5.  Pharmacological analysis of the central cardiovascular effects of four GABA analogues.

Authors:  P Bousquet; J Feldman; R Bloch; J Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-04       Impact factor: 3.000

6.  Age-dependent changes in cardiovascular responses induced by muscimol infused into the nucleus tractus solitarii and nucleus parabrachialis medialis in rats.

Authors:  V Mollace; E A De Francesco; G Fersini; G Nistico
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

7.  Baclofen prevents the increase of myocardial oxygen demand indexes evoked by the hypothalamic stimulation in rabbits.

Authors:  E Tibirica; L Monassier; J Feldman; C Brandt; A Verdun; P Bousquet
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-08       Impact factor: 3.000

8.  Influence of gamma-aminobutyric acid on the changes of blood pressure in rats.

Authors:  D Y Lim; J Suh; H J Yoo; W S Kim; S B Kim; S K Lee; S I Lee; S P Hong
Journal:  Korean J Intern Med       Date:  1990-01       Impact factor: 2.884

9.  Gamma-aminobutyric acid production using immobilized glutamate decarboxylase followed by downstream processing with cation exchange chromatography.

Authors:  Seungwoon Lee; Jungoh Ahn; Yeon-Gu Kim; Joon-Ki Jung; Hongweon Lee; Eun Gyo Lee
Journal:  Int J Mol Sci       Date:  2013-01-15       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.